|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
12/30/15 Quart Barry D 4 Dir.,Off.² 2:8K Heron Therapeutics, Inc./DE DONNELLEY FIN… File16/FA
12/24/15 Quart Barry D 4 Dir.,Off.² 2:7K Heron Therapeutics, Inc./DE DONNELLEY FIN… File16/FA
10/15/15 Quart Barry D 4 Dir.,Off.² 2:8K Heron Therapeutics, Inc./DE DONNELLEY FIN… File16/FA
9/30/15 Quart Barry D 4 Dir.,Off.² 2:8K Heron Therapeutics, Inc./DE DONNELLEY FIN… File16/FA
8/19/15 Quart Barry D 4 Dir.,Off.² 2:10K Heron Therapeutics, Inc./DE DONNELLEY FIN… File16/FA
3/4/15 Quart Barry D 4 Dir.,Off.² 2:7K Heron Therapeutics, Inc./DE DONNELLEY FIN… File16/FA
12/15/14 Quart Barry D 4 Dir.,Off.² 2:11K Heron Therapeutics, Inc./DE DONNELLEY FIN… File16/FA
1/7/14 Quart Barry D 4 Dir.,Off.² 2:14K Heron Therapeutics, Inc./DE Ropes & Gray LLP
12/22/11 Quart Barry D 4 Director² 2:7K Synageva Biopharma Corp. R R Donnelley … Filer/FA
6/29/07 Quart Barry D 3 Director² 2:4K Synageva Biopharma Corp. R R Donnelley … Filer/FA
____________ | ¹ | Filing/Form Types: | | 3 | Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }. | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|